Moderna (MRNA) Change in Inventory (2020 - 2026)
Moderna (MRNA) posted quarterly Change in Inventory of $132.0 million for Q2 2026, up 15.79% year-over-year from $114.0 million in Q2 2025, and up 2300.0% on a QoQ basis from -$6.0 million in Q1 2026.
Moderna (MRNA) Change in Inventory (2020 - 2026) Analysis & Trends
Moderna has reported Change in Inventory for 7 years, with the latest figure at $132.0 million in Q2 2026.
- Change in Inventory for Q2 2026 came in at $132.0 million, up 15.79% year-over-year; the trailing twelve-month figure through Jun 2026 was $38.0 million (up 124.05% YoY), and the FY2025 annual result was $34.0 million, up 140.96% from the prior year.
- Change in Inventory rose to $132.0 million in Q2 2026, from -$6.0 million in the prior quarter.
- Over five years, Change in Inventory peaked at $501.0 million in Q1 2022 and troughed at -$1.1 billion in Q4 2022.
- A 5-year average of -$64.6 million and a median of $1.0 million in 2025 frame the typical range for Change in Inventory.
- The widest annual swing landed in 2022, when Change in Inventory sank 336.97%; it then jumped 727.27% in 2025.
- A 5-year view of Change in Inventory shows it stood at -$1.1 billion in 2022, then surged by 74.73% to -$285.0 million in 2023, then fell by 2.11% to -$291.0 million in 2024, then surged by 38.49% to -$179.0 million in 2025, then surged by 173.74% to $132.0 million in 2026.
- Per Business Quant data, the three most recent Change in Inventory figures were $132.0 million in Q2 2026, -$6.0 million in Q1 2026, and -$179.0 million in Q4 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 27.70 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 28.20 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 47.15 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -2,188.52 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -280,000.00 |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 12.97 Mn |
| 10 | Moderna | 25.26 Bn | 20.13 Bn | 52.00 Mn | 132.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 132.00 Mn |
| Jun 30, 2026 | 132.00 Mn |
| Mar 31, 2026 | -6.00 Mn |
| Mar 31, 2026 | -6.00 Mn |
| Dec 31, 2025 | -179.00 Mn |
| Dec 31, 2025 | -179.00 Mn |
| Sep 30, 2025 | 91.00 Mn |
| Sep 30, 2025 | 91.00 Mn |
| Jun 30, 2025 | 114.00 Mn |
| Jun 30, 2025 | 114.00 Mn |
| Mar 31, 2025 | 8.00 Mn |
| Mar 31, 2025 | 8.00 Mn |
| Dec 31, 2024 | -291.00 Mn |
| Dec 31, 2024 | -291.00 Mn |
| Sep 30, 2024 | 11.00 Mn |
| Sep 30, 2024 | 11.00 Mn |
| Jun 30, 2024 | 104.00 Mn |
| Jun 30, 2024 | 104.00 Mn |
| Mar 31, 2024 | 93.00 Mn |
| Mar 31, 2024 | 93.00 Mn |